Weight & Metabolic
Retatrutide
Retatrutide is a triple agonist that activates GLP-1, GIP and glucagon receptors. Its research profile combines appetite regulation with metabolic signaling and fat metabolism. The three-receptor approach is being explored for advanced weight-management and metabolic applications.
What is it researched for?
Primary research focus: Weight & Metabolic. This description is not a medical indication.
Presentations & pricing
10mg · $855
Request this product
Select a presentation above to update the vial, label and inquiry. The team confirms availability and next steps.
Research information only; this page does not provide dosing, prescribing or treatment instructions. Verify regulatory status and documentation for the applicable product and lot.

